About: Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2005

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2005 (uk) artículu científicu espublizáu n'agostu de 2005 (ast) scientific article published on 01 August 2005 (en)
publication date	wds:Q81084956-7E551459-5AF8-4FBE-BAF7-D4563F682597
publication date	2005-08-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q81084956-C5232EEE-F554-4B1C-BB6D-FCC5B34091AE wds:Q81084956-D5E410A1-65EA-46EA-9C7B-4AD55E044841 wds:Q81084956-D92E3B31-9B2A-46C8-A1E2-4611F1D21B74 wds:Q81084956-F1942634-12D6-455A-ABC3-6F2BE67DB894 wds:Q81084956-FCFE70D6-3C4C-4615-824A-56684F493CC0
author name string	Helgi Birgisson Ulf Gunnarsson Joakim Folkesson Lars Pahlman Bjorn Cedermark
rdfs:label	Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate (en) Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate (nl)
skos:prefLabel	Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate (en) Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate (nl)
name	Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate (en) Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate (nl)
author	wds:Q81084956-00299CFB-5904-4072-91E6-6ED5DE77D0D6
author	Bengt Glimelius
title	wds:Q81084956-1BB2C77E-87E6-410B-91F6-F3261DF49749
title	Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate (en)
page(s)	wds:Q81084956-D172298A-966C-4ADB-9D3D-01804473A6CA
page(s)	5644-5650
instance of	wds:Q81084956-C18CDCB6-B652-4266-9D2A-BB823CDC68BA
instance of	scholarly article
PubMed ID	wds:Q81084956-262991CF-7949-4A7C-AE38-CBA82AFA1035
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16110023
PubMed ID	16110023
published in	wds:Q81084956-0EDCCC18-5DD9-4B37-98ED-A734ED647A9D
published in	Journal of Clinical Oncology
issue	wds:Q81084956-13B7B42B-DF2E-400D-9E0A-409AECF71F5A
volume	wds:Q81084956-54A7D4B1-0D35-4D4F-ADE8-5A57FF3662AB
issue	24
volume	23
DOI	wds:Q81084956-CF1F0BC7-A214-4F6E-A8A1-107E033FFBC4
DOI	http://dx.doi.org/10.1200/JCO.2005.08.144
DOI	10.1200/JCO.2005.08.144
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81084956
is cites work of	Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer The emerging role of neoadjuvant chemotherapy for rectal cancer Differences in the therapeutic approach to colorectal cancer in young and elderly patients Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Comparative analysis of radiosensitizers for K-RAS mutant rectal cancers Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future Treatment of locally advanced rectal cancer: controversies and questions Colorectal cancer In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial Neo-adjuvant radiotherapy in rectal cancer Rectal cancer : when is the local recurrence risk low enough to refrain from the aim to prevent it? Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer: Does Time to Surgery Matter? Local excision for early rectal cancer: transanal endoscopic microsurgery and beyond Role of surgery for colorectal cancer in the elderly The current landscape of locally advanced rectal cancer Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer ACR appropriateness criteria® resectable rectal cancer Management of primary rectal cancer by surgeons in Atlantic Canada: results of a regional survey. Adjuvant therapy for rectal cancer Short-course versus long-course chemoradiation in rectal cancer--time to change strategies? Aims of combined modality therapy in rectal cancer (M0). Lateral lymph node dissection for lower rectal cancer Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial. Review of systemic therapies for locally advanced and metastatic rectal cancer Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer PHD inhibition mitigates and protects against radiation-induced gastrointestinal toxicity via HIF2. [Problems in the treatment of upper rectal carcinoma] Quantification and characterization of radiation-induced changes to mandibular vascularity using micro-computed tomography Preoperative and adjuvant treatment of localized rectal cancer Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Transforming growth factor beta-1 in rectal tumour, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients Matrix metalloproteinases in rectal mucosa, tumour and plasma: response after preoperative irradiation Modified neoadjuvant short-course radiation therapy in uT3 rectal carcinoma: low local recurrence rate with unchanged overall survival and frequent morbidity A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database. The current state of targeted agents in rectal cancer MAP17 (PDZK1IP1) and pH2AX are potential predictive biomarkers for rectal cancer treatment efficacy Lymph node metastasis of carcinomas of transverse colon including flexures. Consideration of the extramesocolic lymph node stations Rate of pulmonary metastasis varies with location of rectal cancer in the patients undergoing curative resection Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. Gender-related differences in repopulation and early tumor response to preoperative radiotherapy in rectal cancer patients. Individualizing treatment for locally advanced rectal cancer Radiotherapy response in microsatellite instability related rectal cancer Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software